 |
Nitric oxide |
|---|---|
| Trade Name | Inomax |
| Orphan Indication | Persistent pulmonary hypertension in the newborn |
| USA Market Approval | USA |
| USA Designation Date | 1993-06-22 00:00:00 |
| Sponsor | Mallinckrodt Hospital Products;1425 U.S. 206;Bedminster Township, New Jersey, 07921 |
